June 1, 2015
Arsenal Medical and 480 Biomedical today announced $26.5 million in combined funding from a committed syndicate of investors to advance their respective product platforms. Arsenal Medical, a company developing novel, polymer based foam and nanofiber products, raised $16 million from Polaris Partners, North Bridge Venture Partners, and Intersouth Partners. 480 Biomedical, a clinical stage company developing innovative bioresorbable scaffold products, raised $10.5 million from the same syndicate in conjunction with a long term strategic investor. Both rounds included a conversion of debt, in addition to new equity financing.
February 25, 2015
CBS Boston
It looks like a simple caulking gun. But it’s no ordinary tool. “The potential impact is truly revolutionary,” says Dr. David King.
January 29, 2015
Boston Magazine
The new technology may be able to extend life up to three hours.
January 15, 2015
Business Wire
Data supporting clinical use of foam system presented at the 28th Eastern Association for the Surgery of Trauma (EAST) Annual Scientific Assembly in Orlando, Florida
June 1, 2013
Economist
ON OBSERVING that most injured soldiers died before receiving medical attention, Dominique-Jean Larrey, a young surgeon in Napoleon’s army, proposed installing surgical teams near the front lines. Horse-drawn carriages would whisk the wounded from the battlefield to the closest field hospital, dramatically reducing casualties. Today the whisking is done by helicopter or ambulance and the treatment on arrival is incomparably better.
March 5, 2013
WGBH
About 25 percent of battlefield casualties are medically preventable, according to the Army Institute of Surgical Research. But what if there was something that could buy that wounded soldier time? One local company is working on doing just that.
December 10, 2012
Novel Arsenal foam technology to stabilize soldiers with severe abdominal hemorrhage, addressing major source of battlefield mortality.
